Title: Aarkstore - The Chinese Pharmaceuticals Market to 2024
1Aarkstore - The Chinese Pharmaceuticals Market
to 2024
Category Healthcare
2Aarkstore - The Chinese Pharmaceuticals Market to
2024
3Summary
- The OTC drugs market in China was characterised
by a late start, but fast growth, along with huge
potential in comparison to that of the mature OTC
markets in many western countries. Your company
should be benefiting from this market access
and this is only the OTC market what has the
growth been throughout the whole Chinese pharma
sector? This report will tell you.Chinas
pharmaceutical sales growth is based on economic
growth in the country This has resulted in
increased healthcare expenditure internally, and
increased manufacture and export. Increasing
urbanisation, disposable income, aging
population, health education, lifestyle diseases
and government investments and initiatives for
healthcare infrastructure improvement have helped
the market growth considerably. Have you captured
enough of the Chinese market?
4Annually, an average of 190 is spent for the
treatment of diabetes, per patient, in China. By
2030, in China, diabetes is expected to cost Yuan
173.4bn (28 bn) a year. China is expected to top
the worlds diabetes tables both in terms of
sheer numbers and population prevalence. This is
true across a range of complaints and products
types your company must capture a segment of
this market TODAY.Anti-Counterfeiting and
anti-corruption How the Chinese market is
changingCounterfeit drugs are successfully
introduced in to the lengthy and complicated
delivery chain because of the highly fragmented
nature of the market. A lack of regular
inspections by any recognised drug enforcement /
regulatory bodies, again due to the highly
fragmented nature of production, allows
counterfeit / poor quality drugs into the Chinese
pharma market. Moreover, wide spread corruption
also helps the distribution of counterfeit drugs.
What are the Chinese regulators, and the global
manufacturers doing to change this? Find out in
this unique report.
5Table of Contents
- Executive Summary 1.1. Chinese Pharmaceutical
Market Review 1.2. Chapter Breakdown 1.3.
Research and Analysis Methods 2. Drivers
Restraints of the Chinese Pharmaceutical
Market 2.1 An Ageing Population will drive
pharmaceutical market growth in China 2.2
Increase in Chinese urbanisation 2.3 Increase
in Healthcare expenditure will increase drug
demand in China 2.4 Government policies and
changing environment for MNCs in China 2.5
Increased demand for improved drug quality
6List Of Tables
- Table 2.1.1 Percentage of Chinese population
aged 60 and over / 65 and over in 2000, 2011
2016 Table 2.1.2 Health spending in China,
India and the US, 2009 2011 (/p/a percentage
change) Table 2.1.3 Total Health Expenditure
(as of GDP) Selected Countries 2004 to
2011 Table 2.1.4 Life expectancy Selected
Countries 2004 to 2011 Table 2.2.1 Medical
Coverage for Rural / Urban inhabitants in China
2006 / 2009 (million people) Table 2.2.2
Major cities in China by population
(2011) Table 2.3.1 Chinas Health Care
Expenditure Per Capita 2003-2011 Table 2.6.1
Key New Drugs on the 2012 Essential Drugs List -
7List Of Figures
- Figure 2.1.1 China population growth
trend 1950-2013Figure 2.1.2 Projected
comparison of Chinas population vs. other
heavily populated countries 2016 (million
people)Figure 2.1.3 Chinas Age distribution
2001 to 2011Figure 2.1.4 Life expectancy in
ChinaFigure 2.2.1 Chinas Rural and Urban
population from 1990 to 2025 Billion
PeopleFigure 2.2.2 Chinas Urbanisation Rate
1990-2025 ()Figure 2.2.3 Per Capita
Disposable Income Figure 2.3.1 China GDP
growth trend (2004 2012)Figure 2.3.2 Chinas
total health expenditure (as of GDP) 2004 to
2011Figure 2.3.3 China healthcare expenditure
per capita growth trend (2003 2011) -
8Related Reports
- Generic Drugs Market in Japan 2015-2019
- Lung Cancer-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2015 - Metastatic Brain Tumor-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2015 - Lupus Erythematosus-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2015 - Metastatic Breast Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
9Related Reports
- Malaria-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Metastatic Colorectal Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015 - Melanoma-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Metastatic Hormone Refractory (Castration
Resistant, Androgen-Independent) Prostate
Cancer-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Pharmaceuticals Healthcare Market Research
Reports
10The Chinese Pharmaceuticals Market to
2024 Published Sep 2014 160 Pages Chinas
pharmaceutical sales growth is based on economic
growth in the country This has resulted in
increased healthcare expenditure internally, and
increased manufacture and export.
Format Price
PDF 1799
Site License 3599
Enterprise Wide Licence 8499
11Contact Us
- Office
- Office No. - 809, 8th Floor,
- B-Wing, Mahaavir Icon,
- Plot No.- 89 90, Sector-15,
- CBD-Belapur, Navi Mumbai 400614,
- Maharashtra, India.
- Telefax No 91 22 4127 6660
- 24/7 Online Support 91 9987295242
- General Inquiries 91 - 22 2756 4953
- You Can Visit
- http//www.aarkstore.com
- OR Mail us at
- contact_at_aarkstore.com
- Blog
- http//www.aarkstore.com/blog/
- Conference
- http//conference.aarkstore.com/
- News
- http//www.aarkstore.com/news